Introduction
Despite advances in diabetes management, hypoglycaemia still remains a major adverse effect of insulin treatment and barrier to achieve optimal glycaemic control in diabetes [
1]. Hypoglycaemia accounts for significant morbidity, mortality, worry and impacts on quality-of-life, employment and ability to drive in people with type 1 diabetes mellitus [
2‐
7].
The widespread use of intensified insulin treatment and lower glycaemic targets in the management of type 1 diabetes mellitus may promote the development of impaired awareness of hypoglycaemia (IAH) [
8]. IAH results in a marked reduction in hypoglycaemic symptoms and is also associated with attenuated counterregulatory hormonal responses to hypoglycaemia [
8]. Therefore, IAH results in inappropriate behavioural and physiological responses to restore blood glucose that leave patients exposed to the effects of hypoglycaemia more frequently and for a longer duration [
9]. Furthermore, increased recent and recurrent exposure to hypoglycaemia leads to further impairment of awareness [
10].
Recognition and assessment of IAH is critical to direct appropriate medical, behavioural and educational treatment [
11]. Structured education, such as DAFNE (Dose Adjustment for Normal Eating), and new diabetes technologies, such as CGM (continuous glucose monitoring) and CSII (continuous subcutaneous insulin infusion), are used to reduce to reduce episodes of severe hypoglycaemia and restore awareness of hypoglycaemia [
11‐
14]. Assessment of IAH is also important for meeting current European driving standards [
7]. Current strategies to assess IAH in clinical settings rely on the use of validated methods based on patient questionnaires. Three validated methods have been used extensively in this regard [
9,
15,
16]. This study aims to compare three validated methods used to assess impaired awareness of hypoglycaemia in a large city teaching hospital. The prevalence of IAH and its associations with features of IAH and patient characteristics were investigated. This retrospective study also illustrated the difficulty in recognising IAH in clinical settings. The aims of this study are to compare the validated questionnaire-based methods for assessing IAH with clinical characteristics and clinical features of hypoglycaemia unawareness and therefore to provide an assessment of accuracy for these methods in assessing IAH.
Methods
Study Population
One hundred adults with type 1 diabetes mellitus attending an urban adult diabetes outpatient clinic between January 2016 and August 2016 undertook a routine clinic questionnaire detailed below. Exclusion criteria consisted of pregnancy, advance renal failure and inability to understand or complete the questionnaire. Four adults were unable to complete the questionnaire. Two were excluded because of language difficulties and a further two were excluded because of incomplete responses. A member of the clinical team was present to assist with clarification of the content of the questionnaire if needed. Baseline demographic and clinical information was assessed using patient records. Haemoglobin A1c was measured using a standard method on the Menarini HA-8160 (Menarini Pharma, UK) analyser. The results were Diabetes Control and Complications Trial (DCCT) aligned; the local reference range for HbA1c is 5.0–6.5%.
The study was not required to have institutional review board (IRB) approval as it used existing routine clinical data accessed directly by the clinical team caring for the patients and met local requirements to be undertaken as a clinical audit. No intervention was implemented on the patients for the purpose of the study, and no patient-identifiable information was used in the study. Retrospective analysis of questionnaires used in routine practice was approved as an audit by Imperial College Healthcare NHS Trust Clinical governance office. Informed consent was obtained from all participants at the time of questionnaire completion.
Questionnaire and Assessment of IAH
A single questionnaire incorporated the validated hypoglycaemia awareness scoring methods of Gold et al., Clarke et al. and Pedersen-Bjergaard et al. [
9,
15,
16]. The questionnaire included the question ‘how often in the last month have you had readings < 3.5 mmol/L at night?’ with responses being ‘Never’, ‘1 to 3 times/month’,’1 time/week’, ‘4.5 times/week’ and ‘almost every night’, to assess frequency of nocturnal hypoglycaemia. Hypoglycaemia symptom scores were assessed using the Edinburgh Hypoglycaemia Scale in this questionnaire [
17]. The retrospective recall of severe hypoglycaemia over a period of 1 year, which is a robust measure in people with type 1 diabetes was also assessed in this questionnaire [
18]. A seven-point Likert scale with 1 representing ‘never’ or ‘strongly disagree’ and 7 representing ‘always’ or ‘strongly agree’ was used to assess knowledge to avoid future hypoglycaemic episodes, daytime and night-time worry for hypoglycaemia. IAH and normal awareness (NA) was assessed as per the scoring methods provided by Clarke et al., Gold et al. and Pedersen et al. [
9,
15,
16]. On the Gold and Clarke methods, a score of 4 or more implied IAH [
9,
15]. Using the Pedersen method people who answered ‘usually’ or ‘never’ were considered to have IAH [
16]. Self-reported poor symptoms of hypoglycaemia were also assessed separately as a cause for hypoglycaemia using a seven-point Likert scale with 1 representing ‘strongly disagree’ and 7 representing ‘strongly agree’.
Statistical Analysis
All analyses were performed using SPSS version 14.0 for Windows (SPSS Inc., Chicago, IL, USA). A P value less than 0.05 was considered to be significant. Initial comparisons between hypoglycaemic aware and unaware groups for continuous variables were performed using the two-sample Student’s t test and those for non-continuous variables were performed using a Mann–Whitney U test. For categorical variables, differences in proportions between the groups were compared using the chi-square test or Fisher’s exact test when necessary. To assess the relationship between two variables Spearman’s correlation, Matthews’ correlation coefficient and kappa score were used. All results are reported as mean ± SEM (standard error of mean) unless indicated. Results as mean ± SD (standard deviation) are provided in the supplementary material.
Discussion
This observational study in a large outpatient clinic population utilises and compares three validated methods to assess prevalence and characteristics of people with IAH [
9,
15,
16]. The reported prevalence of IAH using all three methods is in line with recent estimates and is slightly reduced as compared to prevalence of approximately 25–30% using Clarke and Gold methods in older reports [
19‐
21]. A recent report suggests higher prevalence; however, that study enrolled people with type 1 diabetes with ongoing real-time CGM use who may have been recommended or met local funding criteria for real-time CGM on the basis of their awareness status [
22]. The recent reduction in our study compared to older reports may reflect improvements in diabetes treatment, including standardised education. Previous evidence demonstrates that CSII reduces episodes of severe hypoglycaemia and structured education programmes, such as DAFNE, restore awareness of hypoglycaemia [
12,
14]. In this study, no significant differences in treatment and education were noted between people with IAH and normal awareness; however, our study size was not powered to assess differences in this. Given the small number of patients who were excluded, it is unlikely that this has confounded the results. However, it is possible that exclusion of patients with advanced renal impairment from this study may have impacted on prevalence of IAH.
In accordance with previous reports, increased duration of diabetes, age (significant on Clarke method only) and severe hypoglycaemic episodes in the last year (significant on Clarke and Pedersen methods but not Gold method) were noted in people with IAH as compared with normal awareness [
19]. Reduction in autonomic symptoms, one of the hallmarks of IAH, was significant in people with IAH compared to normal awareness, using the Clarke method, but not Gold or Pedersen methods [
5]. This is in contrast to the previous reports suggesting increased age, severe hypoglycaemic episodes and reduced autonomic symptoms using the Gold method in a large study [
20]. This difference is likely due to the decreased sensitivity of the Gold method compared to that of the Clarke method in defining IAH in smaller clinical settings.
The concordance of the three methods to identify IAH was evaluated and values were compared against each other. A previous study that evaluated the concordance between these three questionnaires in identifying people with IAH yielded controversial results [
19,
23]. In keeping with that previous report, the Pedersen method in this study was found to overestimate IAH and was a poor clinical discriminator of IAH and normal awareness [
19]. However, in this study there was a moderate correlation between Clarke and Gold methods. This is in contrast to a previous report suggesting a strong correlation between both methods [
19]. This study details the relationship between the two methods (Fig.
1). Although there is a correlation, our results suggest that this is modest with poor mutual concordance (Fig.
1).
The low sensitivity and positive predictive values of the Gold method against the Clarke method highlight the non-equivalence of these two questionnaires. This is also supported by different patient characteristics and features of IAH between Clarke and Gold methods, especially autonomic symptoms, suggesting that both methods are not equal. These differences may arise from different questionnaire designs. The Gold method relies upon a single-item response. This is more liable to bias, misinterpretation and measurement error as compared to multi-item response questionnaires, such as the Clarke method [
24].
In this study we also demonstrate that IAH defined by the Clarke method is associated with decreased self-reported knowledge to avoid future hypoglycaemic events. Night-time worry and self-reported night-time hypoglycaemia are also increased in IAH people defined by the Clarke method. This highlights opportunities to improve education and behaviour in people with IAH, which may help reduce the incidence of hypoglycaemic episodes and improve long-term control. A stepped care approach of structured education and diabetes technologies, such as CSII and CGM to manage impaired awareness of hypoglycaemia and to reduce episodes of severe hypoglycaemia, has been previously recommended [
25]. Fear and concerns regarding nocturnal hypoglycaemia in people with type 1 diabetes and families can substantially lead to behaviours such as overeating or insulin under-dosing which may impact on glycaemic control and diabetes complications [
26].
One of the limitations of this study is that there is no gold standard test for IAH. Hypoglycaemia trials may benefit from access to patients with confirmed IAH on multiple modalities. Using such cases alongside hypoglycaemia-aware comparators in a prospective questionnaire study may provide the ability to construct more reliable ROC (receiver operating characteristic) analysis. A potential confounding factor that remains unresolved is the potential for demographics in altering the sensitivity of IAH assessment methods. The study was retrospective in nature, and large-scale prospective studies assessing the performance of each questionnaire in predicting the occurrence of severe hypoglycaemia are needed. Nevertheless, this study reveals important real-world insights regarding the utility of questionnaire-based methods for assessing IAH.
Conclusion
This study reveals differences between characteristics of people with IAH defined by Clarke, Gold and Pedersen methods. Care must be taken when using these methods in clinical and research settings given their non-equivalence. The prevalence of IAH was overestimated using the Pedersen method for this cohort of people with type 1 diabetes, concordant with findings from a previous study [
19]. The prevalence of IAH using the Clarke and Gold methods was 18% and 19%, consistent with known evidence.
The National Institute for Health and Care Excellence (NICE) currently recommends the use of the Gold or Clarke scoring tools as methods to assess awareness of hypoglycaemia in people with type 1 diabetes [
27]. Although there is no conclusive diagnostic investigation for IAH, our results suggest that care should be taken when using risk assessment scores and that multiple scoring modalities should be used in clinical settings to ensure validity of results with a reliable risk assessment. Further studies are needed to reassess the performance of questionnaire-based methods in larger populations and correlating them with metrics obtained from recent CGM systems with improved accuracies or prospective occurrence of severe hypoglycaemia episodes [
22]. Future work focusing on CGM metrics and classification of hypoglycaemia awareness using functional brain imaging may provide us with more accurate diagnostic criteria for IAH.
Acknowledgements
The authors would like to thank the clinical team and participants of the study.